Actinomycin D (from Streptomyces parvulus) ≥98% (by TLC)
Supplier: Enzo Life Sciences
|
Danger
|
BML-GR300-0005
89158-858EA
99.19
USD
89158-858
Actinomycin D (from Streptomyces parvulus) ≥98% (by TLC)
Actinomycin D
An intercalating transcription inhibitor and antineoplastic antibiotic
Inhibits transcription by binding to DNA at dG residues. Induces apoptosis in many cell lines, but suppresses in PC12 cells induced by topoisomrease II inhibitor etopside. Used at 5-10 µg/mL in cell culture for halting transcription. The product is not sterile.
Red-orange crystalline solid
Soluble in DMSO (>20 mg/mL), 100% ethanol (1 mg/mL) or methanol
Formula:
C₆₂H₈₆N₁₂O₁₆ MW: 1255.5 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD00005033 CAS Number: 50-76-0 UN: 3462 ADR: 6.1,II |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...